The Northwestern spinout is riding the IPO wave that's lifting biopharma companies. The stock begins trading today on the Nasdaq.
from Chicago Business News http://www.chicagobusiness.com/article/20180621/BLOGS11/180629971/-100-million-for-drug-startup-aptinyx?utm_source=BLOGS11&utm_medium=rss&utm_campaign=chicagobusiness
No comments:
Post a Comment